Abbott Products
11
0
0
8
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 70/100
27.3%
3 terminated/withdrawn out of 11 trials
72.7%
-13.8% vs industry average
45%
5 trials in Phase 3/4
13%
1 of 8 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
The CBF Study Evaluating the Effect of Betahistine on the Cerebral Blood Flow
Role: lead
Evaluation of Safety and Tolerability of Creon Micro in Children Younger Than Four Years With Pancreatic Exocrine Insufficiency
Role: lead
A Safety PK/PD Study of SLV337 in Patients With Type 2 Diabetes
Role: lead
A Phase 2a Dose Escalation Study With SLV334 in Patients With Traumatic Brain Injury.
Role: lead
Effect of Choline Fenofibrate (SLV348) on Macular Edema
Role: lead
14-C ADME (Absorption, Disposition, Metabolism and Excretion) Study in Man
Role: lead
Habitual Abortion Study: Oral Dydrogesterone Treatment During Pregnancy in Women With Recurrent Miscarriage
Role: lead
A Pilot Study to Assess Efficacy and Safety of Pardoprunox as Adjunct Therapy to L-dopa in the Treatment of Patients With Parkinson's Disease Experiencing Motor Fluctuations and Dyskinesia.
Role: lead
First in Man Study With SLV342
Role: lead
Creon After Pancreatic Surgery
Role: lead
Creon 40,000 for Treatment of PEI (Pancreatic Exocrine Insufficiency) Due to Chronic Pancreatitis
Role: lead
All 11 trials loaded